144 related articles for article (PubMed ID: 34144642)
1. Chemokine receptor antagonists with α
DeSantis AJ; Enten GA; Gao X; Majetschak M
J Basic Clin Physiol Pharmacol; 2021 Jun; 33(4):519-523. PubMed ID: 34144642
[TBL] [Abstract][Full Text] [Related]
2. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
[TBL] [Abstract][Full Text] [Related]
3. α
Gao X; Enten GA; McGee MY; Weche M; Majetschak M
Pharmacol Res; 2023 Apr; 190():106730. PubMed ID: 36925091
[TBL] [Abstract][Full Text] [Related]
4. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
5. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
Smith KM; Macmillan JB; McGrath JC
Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
[TBL] [Abstract][Full Text] [Related]
6. Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.
Errasti AE; Velo MP; Torres RM; Sardi SP; Rothlin RP
Br J Pharmacol; 1999 Jan; 126(2):437-42. PubMed ID: 10077236
[TBL] [Abstract][Full Text] [Related]
7. Alpha1-adrenoceptor subtypes mediating vasoconstriction in the carotid circulation of anaesthetized pigs: possible avenues for antimigraine drug development.
Willems EW; Heiligers JP; De Vries P; Kapoor K; Tom B; Villalón CM; Saxena PR
Cephalalgia; 2001 Mar; 21(2):110-9. PubMed ID: 11422093
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human alpha1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways.
Taguchi K; Yang M; Goepel M; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):100-10. PubMed ID: 9521482
[TBL] [Abstract][Full Text] [Related]
9. Involvement of alpha1-adrenoceptors in the basolateral amygdala in modulation of memory storage.
Ferry B; Roozendaal B; McGaugh JL
Eur J Pharmacol; 1999 May; 372(1):9-16. PubMed ID: 10374709
[TBL] [Abstract][Full Text] [Related]
10. Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors.
Takei R; Ikegaki I; Shibata K; Tsujimoto G; Asano T
Jpn J Pharmacol; 1999 Apr; 79(4):447-54. PubMed ID: 10361884
[TBL] [Abstract][Full Text] [Related]
11. α
Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl attenuates alpha1B-adrenoceptor-mediated pulmonary artery contraction.
Sohn JT; Ding X; McCune DF; Perez DM; Murray PA
Anesthesiology; 2005 Aug; 103(2):327-34. PubMed ID: 16052115
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig.
Barbieri A; Santagostino-Barbone MG; Zonta F; Lucchelli A
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):654-61. PubMed ID: 9686942
[TBL] [Abstract][Full Text] [Related]
14. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
McDaid J; Docherty JR
Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
[TBL] [Abstract][Full Text] [Related]
15. ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Brahmadevara N; Shaw AM; MacDonald A
Br J Pharmacol; 2004 Jun; 142(4):781-7. PubMed ID: 15205310
[TBL] [Abstract][Full Text] [Related]
16. Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors.
Floreani M; Quintieri L; Varani K; Dorigo MT; Dorigo P
Eur J Pharmacol; 2008 Aug; 590(1-3):269-75. PubMed ID: 18571646
[TBL] [Abstract][Full Text] [Related]
17. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of alpha1-adrenoceptor subtypes in rat aorta and prostate.
Maruyama K; Suzuki M; Tsuchiya M; Makara Y; Hattori K; Ohnuki T; Watanabe K; Nagatomo T
Pharmacology; 1998 Aug; 57(2):88-95. PubMed ID: 9691228
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
20. Alpha1L-adrenoceptors in canine pulmonary artery.
Flavahan NA; Hales MA; Aleskowitch TD; Gaine SP; Vanhoutte PM
J Cardiovasc Pharmacol; 1998 Aug; 32(2):308-16. PubMed ID: 9700995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]